Cannabigerol is The Next CBD

11.10.21

Learn more about this buzz-worthy ingredient for personal care formulations at booth 1125.

Cannabigerol (CBG) is sometimes known as the the mother cannabinoid since other cannabinoids—like CBD, CBC and THC—are derived from it.  
 
Creo (booth 1125), is an ingredients technology company that focuses on CBG, which it produces using the natural process of fermentation. This California-based company says it can supply bio-identical CBG that is safe and more sustainable, at scale.
 
A growing body of evidence is supporting CBG’s ability to potentially reduce pain and inflammation; soothe and calm redness; combat acne; help protect from UVA damage;  regulate circadian rhythm and detoxification; support wound healing; and help regulate pigmentation.  
 
According to Creo, CBG inhibits UVA-induced cytokine production better than CBD.
 
Creo’s CBG is scientifically supported, THC-free, high potency and quality, vegan, gluten-free, cGMP compliant and high sustainable.
 
Stop by booth 1125 to learn more about your next potential “hero” ingredient.
 
Website: www.creoingredients.com; Tel.: 817-609-2033